A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
- Status
- COMPLETED
- Phase
- N/A
Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)
- Status
- COMPLETED
- Phase
- PHASE1
TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011)
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Metformin on Immuno-virologic Parameters in HIV
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Imipenem/Cilastatin/Relebactam PK in ECMO
- Status
- COMPLETED
- Phase
- PHASE1
A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Olaparib in Cervical Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)
- Status
- COMPLETED
- Phase
- PHASE3
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients
- Status
- COMPLETED
- Phase
- N/A
Serum Bio-markers in Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- N/A
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pediatric and Ambulatory Research in Infectious Diseases
- Status
- RECRUITING
- Phase
- N/A
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Rifampin and the Contraceptive Implant
- Status
- COMPLETED
- Phase
- PHASE4